CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL

被引：128

作者：

Kong, Y. ^{[2
,3
]}

Yoshida, S. ^{[2
]}

Saito, Y.

Doi, T.

Nagatoshi, Y. ^{[4
]}

Fukata, M. ^{[2
]}

Saito, N. ^{[2
]}

Yang, S. M. ^{[3
]}

Iwamoto, C. ^{[2
]}

Okamura, J. ^{[4
]}

Liu, K. Y. ^{[3
]}

Huang, X. J. ^{[3
]}

Lu, D. P. ^{[3
]}

Shultz, L. D. ^{[5
]}

Harada, M.

Ishikawa, F. ^{[1
]}

机构：

[1] RIKEN RCAI, Res Unit Human Dis Models, Tsurumi Ku, Kanagawa 2300045, Japan

[2] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan

[3] Peking Univ, Peoples Hosp, Inst Hematol, Beijing 100871, Peoples R China

[4] Kyushu Natl Canc Ctr, Dept Pediat, Fukuoka, Japan

[5] Jackson Lab, Bar Harbor, ME 04609 USA

来源：

LEUKEMIA | 2008年 / 22卷 / 06期

基金：

美国国家卫生研究院;

关键词：

acute lymphocytic leukemia; stem cells; transplantation;

D O I：

10.1038/leu.2008.83

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The presence of rare malignant stem cells supplying a hierarchy of malignant cells has recently been reported. In human acute myelogenous leukemia (AML), the leukemia stem cells (LSCs) have been phenotypically restricted within the CD34+CD38- fraction. To understand the origin of malignant cells in primary human B-precursor acute lymphocytic leukemia (B-ALL), we established a novel in vivo xenotransplantation model. Purified CD34+CD38+CD19+, CD34+CD38-CD19+ and CD34+CD38-CD19- bone marrow ( BM) or peripheral blood (PB) cells from three pediatric B-ALL patients were intravenously injected into sublethally irradiated newborn NOD/SCID/IL2r gamma(null) mice. We found that both CD34+CD38+CD19+ and CD34+CD38-CD19+ cells initiate B-ALL in primary recipients, whereas the recipients of CD34+CD38-CD10-CD19- cells showed normal human hematopoietic repopulation. The extent of leukemic infiltration into the spleen, liver and kidney was similar between the recipients transplanted with CD34+CD38+CD19+ cells and those transplanted with CD34+CD38-CD19+ cells. In each of the three cases studied, transplantation of CD34+CD38+CD19+ cells resulted in the development of B-ALL in secondary recipients, demonstrating self-renewal capacity. The identification of CD34+CD38+ CD19+ self-renewing B-ALL cells proposes a hierarchy of leukemia-initiating cells (LICs) distinct from that of AML. Recapitulation of patient B-ALL in NOD/SCID/IL2r gamma(null) recipients provides a powerful tool for directly studying leukemogenesis and for developing therapeutic strategies.

引用

页码：1207 / 1213

页数：7

共 50 条

[31] Initial frequency of CD34+/CD38-cells is not correlated with minimal residual disease level in 73 Chinese children with B-cell precursor acute lymphoblastic leukemia [J].

Feng, Jian-Hua ;

Tang, Yong-Min ;

Shen, Hong-Qiang ;

Song, Hua ;

Yang, Shi-Long ;

Shi, Shu-Wen ;

Xu, Wei-Qun .

LEUKEMIA & LYMPHOMA, 2013, 54 (09) :2073-+

[32] In vitro expansion of CD34+CD38- cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia [J].

Sakashita, K. ;

Kato, I. ;

Daifu, T. ;

Saida, S. ;

Hiramatsu, H. ;

Nishinaka, Y. ;

Ebihara, Y. ;

Ma, F. ;

Matsuda, K. ;

Saito, S. ;

Hirabayashi, K. ;

Kurata, T. ;

Uyeni, L. T. N. ;

Nakazawa, Y. ;

Tsuji, K. ;

Heike, T. ;

Nakahata, T. ;

Koike, K. .

LEUKEMIA, 2015, 29 (03) :606-614

[33] A Novel mAb against a Human CD34 Peptide Reacts with the Native Protein on CD34+ Cells [J].

Shams, Mahmood ;

Jeddi-Tehrani, Mahmood ;

Haghighat, Farzaneh Notash ;

Bayat, Ali Ahmad ;

Mahmoudian, Jafar ;

Rezvani, Mohammad Reza .

IRANIAN JOURNAL OF IMMUNOLOGY, 2013, 10 (04) :259-266

[34] HIV-1 infection depletes human CD34+CD38- hematopoietic progenitor cells via pDC-dependent mechanisms [J].

Li, Guangming ;

Zhao, Juanjuan ;

Cheng, Liang ;

Jiang, Qi ;

Kan, Sheng ;

Qin, Enqiang ;

Tu, Bo ;

Zhang, Xin ;

Zhang, Liguo ;

Su, Lishan ;

Zhang, Zheng .

PLOS PATHOGENS, 2017, 13 (07)

[35] Presence of CD34+CD38-CD58- leukemia-propagating cells at diagnosis identifies patients at high risk of relapse with Ph chromosome-positive ALL after allo-hematopoietic SCT [J].

Kong, Y. ;

Xu, L-P ;

Liu, Y-R ;

Qin, Y-Z ;

Sun, Y-Q ;

Wang, Y. ;

Jiang, H. ;

Jiang, Q. ;

Chen, H. ;

Chang, Y-J ;

Huang, X-J .

BONE MARROW TRANSPLANTATION, 2015, 50 (03) :348-353

[36] Notch signals contribute to preserve the multipotentiality of human CD34+CD38-CD45RA-CD90+ hematopoietic progenitors by maintaining T cell lineage differentiation potential [J].

Sanchez-Dominguez, Rebeca ;

Pereira-Mendez, Sonia ;

Gomez, Alba ;

Torrabadella, Marta ;

Azqueta, Carmen ;

Querol, Sergi ;

Barquinero, Jordi ;

Gimeno, Ramon .

EXPERIMENTAL HEMATOLOGY, 2012, 40 (12) :983-993

[37] Human CD34+/KDR+ Cells Are Generated From Circulating CD34+ Cells After Immobilization on Activated Platelets [J].

de Boer, H. C. ;

Hovens, M. M. ;

van Oeveren-Rietdijk, A. M. ;

Snoep, J. D. ;

de Koning, E. J. P. ;

Tamsma, J. T. ;

Huisman, M. V. ;

Rabelink, A. J. ;

van Zonneveld, A. J. .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (02) :408-U370

[38] T-, B- and NK-lymphoid, but not myeloid cells arise from human CD34+CD38-CD7+ common lymphoid progenitors expressing lymphoid-specific genes [J].

Hoebeke, I. ;

De Smedt, M. ;

Stolz, F. ;

Pike-Overzet, K. ;

Staal, F. J. T. ;

Plum, J. ;

Leclercq, G. .

LEUKEMIA, 2007, 21 (02) :311-319

[39] Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients [J].

Piloni, Davide ;

Morosini, Monica ;

Magni, Sara ;

Balderacchi, Alice ;

Cova, Emanuela ;

Inghilleri, Simona ;

D'Armini, Andrea Maria ;

Scudeller, Luigia ;

Antonacci, Filippo ;

Oggionni, Tiberio ;

Meloni, Federica .

EUROPEAN RESPIRATORY JOURNAL, 2016, 48

[40] CD29 of human umbilical cord mesenchymal stem cells is required for expansion of CD34+ cells [J].

Yang, Y. ;

Hu, M. ;

Zhang, Y. ;

Li, H. ;

Miao, Z. .

CELL PROLIFERATION, 2014, 47 (06) :596-603

← 1 2 3 4 5 →